Related Experiment Video
Updated: May 2, 2026
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.8K
Work-exacerbated asthma in a workers' compensation population
1Department of Medicine, University of Toronto, Toronto, Ontario, Canada M5T 2S8.
Occupational Medicine (Oxford, England)
|February 22, 2014
Summary
Work-exacerbated asthma (WEA) affects many workers, with exposure types and lost workdays varying significantly across industries like healthcare and education. Understanding these differences is key to managing occupational asthma.
Area of Science:
- Occupational Medicine
- Pulmonology
- Epidemiology
Background:
- Work-exacerbated asthma (WEA) is a growing occupational health concern.
- A significant portion of the workforce experiences asthma symptoms triggered or worsened by workplace exposures.
Purpose of the Study:
- To characterize workplace exposures and analyze working days lost in relation to WEA within a workers' compensation population.
- To identify patterns of WEA across different industry sectors.
Main Methods:
- Analysis of accepted workers' compensation asthma claims in Ontario over five years.
- Categorization of claims by industry group (services, education, healthcare) and duration of work absence.
- Classification of attributable agents into dusts, smoke, chemicals, and sensitizers.
Main Results:
- 72% of asthma claims met WEA criteria.
- Education sector showed higher dust exposure (65%) and fewer short exacerbations (27%).
- Healthcare sector had more short exacerbations (55%) attributed to sensitizers (41%).
Conclusions:
- The specific agents causing WEA and the resulting worker morbidity differ substantially between industry groups.
- Findings highlight the need for industry-specific prevention and management strategies for occupational asthma.
Related Concept Videos
01:29Asthma-I: Introduction
3.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.6K
01:13Asthma III: Clinical Manifestations
49
Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
49
01:28Asthma I: Introduction
112
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
112
01:24Asthma-III: Symptoms and Complications
3.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.5K
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40